Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 16:16 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Endometrial Rejuvenation Study
NCT04045821 · Reproductive Medicine Associates of New Jersey · NA · terminated · last registry update 2021-05-19 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “low enrollment” | – | Registry record, Reproductive Medicine Associates of New Jersey |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CXCR4 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2022-05-18Also stopped (terminated): Fred Hutchinson Cancer Center, Carmustine + Filgrastim (NCT00669669)
- 2021-12-21Results posted on the registry: City of Hope Medical Center, Filgrastim + Genetically Engineered Lymphocyte Therapy (NCT01318317)
- 2021-09-16Results posted on the registry: Bristol-Myers Squibb, BMS-936564 + Cytarabine (NCT02305563)
- 2021-09-16Also stopped (terminated): Bristol-Myers Squibb, BMS-936564 + Cytarabine (NCT02305563)
- 2021-06-18Results posted on the registry: Siddhartha Ganguly, Bortezomib + Granulocyte colony-stimulating factor (G-CSF) (NCT02703779)
- 2021-06-18Also stopped (terminated): CSL Behring, Autologous enriched CD34+ cell fraction that contains CD34+ cells transduced with lentiviral vector encoding human γ-globinG16D and short-hairpin RNA734 (NCT04091737)
- 2020-10-30Results posted on the registry: Children's Hospital Medical Center, Cincinnati, AMD3100 (NCT00479115)
- 2020-10-20Also stopped (terminated): Washington University School of Medicine, Fludarabine + Busulfan (NCT02750254)
- 2020-09-07Also stopped (withdrawn): Massachusetts General Hospital, AMD3100 + Pembrolizumab (NCT04058145)
- 2020-07-24Also stopped (withdrawn): Jonsson Comprehensive Cancer Center, Aldesleukin + Cellular Therapy (NCT03506802)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision